A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Clinical trial NCT02982486 · UNKNOWN

Trial details

NCT number: NCT02982486
Sponsor: Assaf-Harofeh Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma Bone Sarcoma Chondrosarcoma Gastrointestinal Stromal Sarcoma Ewing's Tumor Metastatic Ewing's Tumor Recurrent Osteosarcoma Desmoplastic Small Round Cell Tumor

Start date: 2017-12-01
Primary completion: 2020-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.